Clinical Development (original) (raw)
Latest News for: clinical development
Medable Introduces Digital Data Flow Agent, Laying the Foundation for End-to-End Agentic Clinical Development
Enid News & Eagle 15 Jun 2026
PALO ALTO, Calif.--(BUSINESS WIRE)--Jun 15, 2026-- ... .
SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral ...
Business Wire 10 Jun 2026
SAN FRANCISCO--(BUSINESS WIRE)-- #biotech--SonoThera Closes Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Ultrasound-Mediated Nonviral Genetic Medicines ... .
Consano Bio to Present Clinical Development of C-1101 for Chronic Sciatica at 2026 BIO International Convention
PR Newswire 10 Jun 2026
Hall will conduct one-on-one meetings with registered investors and potential partners, showcasing the company's business and clinical development strategy and anticipated milestones.
Applied Biologics Receives FDA Clearance to Advance BIOxHEAL Into Phase 3 Clinical Development
Hastings Tribune 09 Jun 2026
SCOTTSDALE, Ariz., June 09, 2026 (GLOBE NEWSWIRE) -- Applied ...
Applied Biologics Receives FDA Clearance to Advance BIOxHEAL Into Phase 3 Clinical Development for Diabetic ...
Nasdaq Globe Newswire 09 Jun 2026
Applied Biologics receives FDA IND clearance for BIOxHEAL, advancing its lead biologic therapy into Phase 3 clinical trials for diabetic foot ulcers ... .
Transitioning a novel mechanism of action into clinical development (Sound Bioventures Management AB)
Public Technologies 08 Jun 2026
"I decided I wanted to develop drugs ... "I became quite an expert in translational medicine, taking the science from a preclinical stage into the clinic," he explains.
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development
Nasdaq Globe Newswire 04 Jun 2026
Ona Therapeutics closes oversubscribed $86.6M Series B financing to advance first-in-class ADCs into clinical development for treatment-resistant cancers ... .
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development (Asabys Partners SGEIC SA)
Public Technologies 04 Jun 2026
... clinical development of lead first-in-class program ONA-255 in breast cancer, toward clinical proof of concept, and advance ONA-389 in colorectal cancer [...].
Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development (Ysios Capital Partners SGEIC SA)
Public Technologies 04 Jun 2026
Proceeds to support clinical development of lead first-in-class program ONA-255 in breast cancer, toward clinical proof of concept, and advance ONA-389 in colorectal cancer ... clinical development.
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
ACCESSWIRE 03 Jun 2026
... planned clinical studies ... Successfully scaling the production of key precursor materials is essential to building a reliable and scalable supply chain capable of supporting future clinical development.
Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program (Onco-Innovations Ltd)
Public Technologies 02 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132205531) .
Altesa BioSciences Appoints Brett Haumann, MBBCh, MBA, to its Board of Directors and Gwen Skloot, MD, ATSF, as Senior Vice President for Clinical Development
PR Newswire 02 Jun 2026
Gwen Skloot, former Therapeutic Area Head, COPD, Asthma, and Chronic Cough at Chiesi Farmaceutici S.p.A., joins Altesa as Senior Vice President, Clinical Development.
PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
Lebanon Express 30 May 2026
IDAHO FALLS, Idaho, May 29, 2026 /PRNewswire/ -- PharmaLogic ...
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
PR Newswire 29 May 2026
"This expanded collaboration with PharmaLogic represents an important step in advancing our manufacturing strategy as we continue to progress [Ac-225]RTX-2358 through clinical development," said Jack Hoppin, Chief Executive Officer of Ratio.
Quotient Sciences Advances AI-Designed Drug Product into Clinical Development
PR Newswire 28 May 2026
Quotient Sciences Clinical Development (PRNewsfoto/Quotient Sciences) ... This milestone represents the beginning of Quotient Sciences' broader strategy focused on integrating AI-enabled approaches across formulation development and clinical workflows.